[Cost analysis of home parenteral nutrition in Spain].

dc.contributor.authorBurgos Peláez, Rosa
dc.contributor.authorVirgili Casas, María Nuria
dc.contributor.authorCuerda Compés, María Cristina
dc.contributor.authorMoreno Villares, José Manuel
dc.contributor.authorOlveira, Gabriel
dc.contributor.authorLuengo Pérez, Luis Miguel
dc.contributor.authorWanden-Berghe Lozano, Carmina
dc.contributor.authorMuñoz Cuadrado, Álvaro
dc.contributor.authorTorres González, Covadonga
dc.contributor.authorCasado Gómez, Miguel Ángel
dc.date.accessioned2025-01-07T12:47:15Z
dc.date.available2025-01-07T12:47:15Z
dc.date.issued2017-03-30
dc.description.abstractIntroduction: Home parenteral nutrition (HPN) improves quality of life, allowing patients to receive nutrition at home and providing a social and labor integration to these patients. Objective: To assess the direct costs of HPN in adult population in Spain. Methods: A literature review of the records of HPN in Spain, carry out by NADYA-SENPE Group (years 2007-2014), was performed. The analysis included the evolution of: patients requiring HPN, number of episodes/patient, mean duration of episodes, description of delivery routes and complications rate. HPN consumption and cost were estimated. Patients were grouped according to their pathological group: benign and malignant. Direct costs (€, 2015) included were: parenteral nutrition bags, delivery sets and costs due to complications. Results: The number of patients who receive HPN has increased over years (2007: 133 patients; 2014: 220 patients). The average number of episodes per patient ranged from 1-2 episodes per year. The average duration of those episodes decreased (2007: 323 days; 2014: 202.8 days). Tunneled catheters were the most used and septic complications were the most common. The average annual cost per patient was estimated at € 8,393.30 and € 9,261.60 for benign and malign disease respectively. Considering that 220 patients required HPN in 2014, an annual cost of € 1,846.524.96 (€ 1,389,910.55 directly due to HPN) and € 2,037,551.90 (€ 1,580,937.50 directly due to HPN) was estimated for patients with benign and malignant pathologies respectively. Conclusions: These results can be used to develop future economic evaluations on HPN and to establish effi cient prioritization strategies to allocate available resources.
dc.identifier.doi10.20960/nh.705
dc.identifier.essn1699-5198
dc.identifier.pmid28421778
dc.identifier.unpaywallURLhttps://doi.org/10.20960/nh.705
dc.identifier.urihttps://hdl.handle.net/10668/24929
dc.issue.number2
dc.journal.titleNutricion hospitalaria
dc.journal.titleabbreviationNutr Hosp
dc.language.isoes
dc.organizationSAS - Hospital Universitario Torrecárdenas
dc.page.number271-276
dc.pubmedtypeJournal Article
dc.rightsAttribution-ShareAlike 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/
dc.subject.meshAged
dc.subject.meshCosts and Cost Analysis
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshParenteral Nutrition, Home
dc.subject.meshQuality of Life
dc.subject.meshSpain
dc.title[Cost analysis of home parenteral nutrition in Spain].
dc.title.alternativeEstimación del coste de la nutrición parenteral domiciliaria en España.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number34

Files